Skip to main content

Board & Committees

Members

Board member
Mikael Worning
Chair of the Board, Chair of Renumeration Committee, and Member of Audit Committee
Born: 1962
Elected: 2020
Shares: 2360

Education: Cand. Polit., Economics.

Other directorships: Chairman of Tandlægen.dk - Holding A/S. Ordinary board member in Sonion A/S and Colony ApS. Former senior positions at Demant A/S, including President Demant Inc.

Independent of company and major shareholders.

Board member
Christer Fåhraeus
Founder, Board Member, and Member of Renumeration Committee
Born: 1965
Elected: 1994
Shares: 1728399

Education: B.Sc. Medicine, M.Sc. Bioengineering, B.Sc. Mathematics, Ph.D. Neurophysiology, Ph.D. Engineering (hc), Graduate from Swedish armed forces language school.

Other directorships: President/CEO of EQL Pharma AB (publ). Chairman of the Board Bionamic AB. Board member Flatfrog Laboratories AB, Reccan AB, EQL Pharma AB (publ), Amniotics AB (publ), and Gasporox AB (publ). Founder of EQL Pharma AB and Flatfrog Laboratories AB, among others.

Independent of company. Dependent on major shareholders.

Ann-Charlotte Jarleryd
Ann-Charlotte Jarleryd
Board Member, Chair of Audit Committee, and Member of Renumeration Committee
Born: 1966
Elected: 2022

Education: B.Sc. Business Administration, University Diploma in Journalism.

Other directorships: Board member Exsitec Holding. Former experiences include CFO at Addnode Group, Acando and Protect Data, Board member Metria, and authorized public accountant at PwC.

Independent of company and major shareholders.

Louise Armstrong-Denby
Louise Armstrong-Denby
Board Member
Born: 1972
Elected: 2023

Education: M.Sc. Advanced Analytical Chemistry, Ph.D. Analytical Chemistry.

Other directorships: Chief Commercial Officer at Visiopharm 2019-2023, a company active in digital pathology. Former experiences include Chief Sales Officer at Random 42 and Global Sales Director at Andor Technology. Also many years of experience from PerkinElmer.

Independent of company and major shareholders.

Board member
Stefan Wolf
Board Member
Born: 1964
Elected: 2018

Education: Biological Laboratory Science.

Other directorships: CEO of The Binding Site Group Ltd. Former experiences include CEO of Hemostasis, Hematology, and Specialty Diagnostics at Siemens Healthineers and Division President of Clinical Diagnostic Division at Thermo Fisher Scientific.

Independent of company and major shareholders.

Kent stråhlen
Kent Stråhlen
Board Member
Born: 1968
Elected: 2022
Shares: 1000

Education: Ph.D. Applied Mathematics.

Employed since 2000. Current position, Product Manager.

Board member appointed by the unions since 2022.

Gunnar Brun Hansen
Gunnar Brun Hansen
Board Member
Born: 1979

Education: M.Sc. Engineering Physics.

Employed since 2005. Current position, Engineering Manager.

Board member appointed by the unions since 2020.

People in a meeting

Nomination Committee

Ahead of the Annual General Meeting in 2024, the Nomination Committee consists of: Christer Fåhraeus (appointed by Christer Fåhraeus with Companies), Nicklas Hansen (appointed by William Demant Invest A/S), Anette Andersson (appointed by SEB Investment funds), and Emil Hjalmarsson (appointed by Grenlunden CEVI AB). 

Shareholders wishing to submit proposals to the Nomination Committee can email ir@cellavision.com or ordinary mail to: The Nomination Committee, CellaVision AB, Mobilvägen 12, 223 62 Lund.

People in a meeting

Audit & Remuneration Committees

Audit Committee
The CellaVision Audit Committee was appointed within the Board in 2011. The committee comprises Mikael Worning, and Ann-Charlotte Jarleryd (Chairman).

Remuneration Committee
The CellaVision Remuneration Committee was appointed within the Board in 2011. The committee comprises Christer Fåhraeus, Ann-Charlotte Jarleryd and Mikael Worning (Chairman).